Schönharting, W.; Roehnisch, T.; Manoochehri, M.; Christoph, J.; Sieger, M.; Nogueira, M.; Martos-Contreras, M.C.; Kunz, M.
Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization. Vaccines 2023, 11, 1023.
https://doi.org/10.3390/vaccines11061023
AMA Style
Schönharting W, Roehnisch T, Manoochehri M, Christoph J, Sieger M, Nogueira M, Martos-Contreras MC, Kunz M.
Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization. Vaccines. 2023; 11(6):1023.
https://doi.org/10.3390/vaccines11061023
Chicago/Turabian Style
Schönharting, Wolfgang, Tim Roehnisch, Mehdi Manoochehri, Jan Christoph, Marie Sieger, Mauro Nogueira, Mari Carmen Martos-Contreras, and Meik Kunz.
2023. "Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization" Vaccines 11, no. 6: 1023.
https://doi.org/10.3390/vaccines11061023
APA Style
Schönharting, W., Roehnisch, T., Manoochehri, M., Christoph, J., Sieger, M., Nogueira, M., Martos-Contreras, M. C., & Kunz, M.
(2023). Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization. Vaccines, 11(6), 1023.
https://doi.org/10.3390/vaccines11061023